NEXPRO RD 20 MG CAP

1. All Details: Specifications
Reference Product Identification Code: RB/TRP/NX2/ASP/01
Internal Manufacturing Number: 8073029-9092
Drug Classification Panel: SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
Manufacturing License Number (Mfg. Lic. No.): JK/01/11-12/182
2. General Information
Brand Name: NEXPRO RD 20
Generic Product Name: Esomeprazole Magnesium And Domperidone Sustained Release Capsules
Product Type: Prescription Gastrointestinal (Antacid / Promotility) Medication
Form Factor: Hard gelatin capsules containing multi-layered components (an enteric-coated tablet combined with sustained-release pellets)
Quantity: Product is packaged in standard multi-unit pharmaceutical strips.
Maximum Shelf Life: Explicit manufacturing or expiry stamps are not fully visible in this specific frame section, but the product standard stability complies with its pharmaceutical registration.
Food Preference & FSSAI: Not Applicable. This is a therapeutic medicinal formulation regulated under global drug frameworks rather than a standard commercial supplement or food item. For this reason, it carries a mandatory red-bordered prescription cautionary statement instead of an FSSAI layout or food preference icons.
3. Product Details: Ingredients
Each hard gelatin capsule contains:
Esomeprazole Magnesium Trihydrate IP equivalent to Esomeprazole: 20 mg (as an enteric-coated tablet)
Domperidone Maleate IP equivalent to Domperidone: 30 mg (as uncoated bilayered sustained-release pellets)
Approved Colouring Agents: Titanium Dioxide IP used in the hard gelatin capsule shell; Red Oxide of Iron and Titanium Dioxide IP used in the enteric-coated tablet core.
4. Directions: How to Use
Dosage Guidance: Administer exactly as directed by the Physician.
Storage Protocols: Store below 25°C. Protect from light and moisture.
General Safety Warning: Keep all medicines out of reach of children.
5. Description
Product Overview: Nexpro RD 20 is a targeted combination medication combining a proton pump inhibitor (Esomeprazole, 20 mg) and a prokinetic agent (Domperidone, 30 mg). It is commonly used to treat gastroesophageal reflux disease (GERD), acid acidity, and associated nausea or dyspepsia. The formulation releases the ingredients strategically using an enteric-coated system alongside sustained-release technology to manage symptoms continuously over hours.
Visual Presentation: The medication is secured in an Alu-Alu (aluminum-aluminum) cold-formed blister strip. The design incorporates metallic silver foil accented with striking purple horizontal branding bars containing the name “NEXPRO RD 20” in crisp white text. Text details alternate between black and purple fonts, with a highly recognizable red box outlining its controlled Schedule H prescription drug classification.
6. Manufacturer Information
Manufactured In India By: Ravenbhel Biotech
Plant Manufacturing Address: EPIP, SIDCO, Kartholi, Bari-Brahmana Jammu-181133.
7. Marketed By
Marketed By: TORRENT PHARMACEUTICALS LTD.